- Home
- ANEB vs CRIS Comparison
ANEB vs CRIS Comparison
Compare ANEB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- CRIS
- Stock Information
- Founded
- ANEB 2020
- CRIS 2000
- Country
- ANEB United States
- CRIS United States
- Employees
- ANEB N/A
- CRIS N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANEB Health Care
- CRIS Health Care
- Exchange
- ANEB Nasdaq
- CRIS Nasdaq
- Market Cap
- ANEB 36.7M
- CRIS 32.8M
- IPO Year
- ANEB 2021
- CRIS 2000
- Fundamental
- Price
- ANEB $0.98
- CRIS $1.22
- Analyst Decision
- ANEB Buy
- CRIS Strong Buy
- Analyst Count
- ANEB 1
- CRIS 3
- Target Price
- ANEB $8.00
- CRIS $21.00
- AVG Volume (30 Days)
- ANEB 37.4K
- CRIS 90.1K
- Earning Date
- ANEB 05-14-2025
- CRIS 05-06-2025
- Dividend Yield
- ANEB N/A
- CRIS N/A
- EPS Growth
- ANEB N/A
- CRIS N/A
- EPS
- ANEB N/A
- CRIS N/A
- Revenue
- ANEB N/A
- CRIS $10,908,000.00
- Revenue This Year
- ANEB N/A
- CRIS N/A
- Revenue Next Year
- ANEB N/A
- CRIS $27.88
- P/E Ratio
- ANEB N/A
- CRIS N/A
- Revenue Growth
- ANEB N/A
- CRIS 8.83
- 52 Week Low
- ANEB $0.80
- CRIS $1.02
- 52 Week High
- ANEB $3.30
- CRIS $16.99
- Technical
- Relative Strength Index (RSI)
- ANEB 35.89
- CRIS 26.05
- Support Level
- ANEB $0.94
- CRIS $1.06
- Resistance Level
- ANEB $1.12
- CRIS $1.30
- Average True Range (ATR)
- ANEB 0.14
- CRIS 0.22
- MACD
- ANEB -0.03
- CRIS -0.01
- Stochastic Oscillator
- ANEB 11.17
- CRIS 20.00
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.